共 50 条
- [33] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation [J]. JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
- [35] Bleeding and Thromboembolic Events in Patients with Non-Valvular Atrial Fibrillation Treated with Apixaban or Rivaroxaban [J]. MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2022, 29 (02): : 164 - 172
- [36] Apixaban vs. Warfarin in Atrial Fibrillation Patients With Chronic Kidney Disease [J]. FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
- [37] Apixaban Patients with Atrial Fibrillation protective [J]. ZEITSCHRIFT FUR ORTHOPADIE UND UNFALLCHIRURGIE, 2012, 150 (03): : 247 - 247